| Cell-free chromatin from dying cancer cells integrate into genomes of bystander healthy cells to induce DNA damage and inflammation I Mittra, U Samant, S Sharma, GV Raghuram, T Saha, P Tidke, N Pancholi, ... Cell Death Discovery 3 (1), 1-14, 2017 | 56 | 2017 |
| ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer P Iyer, SV Shrikhande, M Ranjan, A Joshi, N Gardi, R Prasad, ... International journal of cancer 144 (8), 2008-2019, 2019 | 46 | 2019 |
| Metabolic rewiring in drug resistant cells exhibit higher OXPHOS and fatty acids as preferred major source to cellular energetics S Salunkhe, SV Mishra, A Ghorai, A Hole, P Chandrani, A Dutt, ... Biochimica et Biophysica Acta (BBA)-Bioenergetics 1861 (12), 148300, 2020 | 32 | 2020 |
| Up-regulation of the kinase gene SGK1 by progesterone activates the AP-1–NDRG1 axis in both PR-positive and-negative breast cancer cells M Godbole, T Togar, K Patel, B Dharavath, N Yadav, S Janjuha, N Gardi, ... Journal of Biological Chemistry 293 (50), 19263-19276, 2018 | 32 | 2018 |
| Inhibition of SETMAR–H3K36me2–NHEJ repair axis in residual disease cells prevents glioblastoma recurrence E Kaur, J Nair, A Ghorai, SV Mishra, A Achareker, M Ketkar, D Sarkar, ... Neuro-oncology 22 (12), 1785-1796, 2020 | 25 | 2020 |
| Inhibition of novel GCN5–ATM axis restricts the onset of acquired drug resistance in leukemia S Salunkhe, SV Mishra, J Nair, S Ghosh, N Choudhary, E Kaur, S Shah, ... International journal of cancer 142 (10), 2175-2185, 2018 | 23 | 2018 |
| Molecular features unique to glioblastoma radiation resistant residual cells may affect patient outcome-a short report E Kaur, JS Goda, A Ghorai, S Salunkhe, P Shetty, AV Moiyadi, E Sridhar, ... Cellular oncology 42, 107-116, 2019 | 18 | 2019 |
| Bloom helicase mediates formation of large single–stranded DNA loops during DNA end processing C Xue, SJ Salunkhe, N Tomimatsu, AS Kawale, Y Kwon, S Burma, P Sung, ... Nature communications 13 (1), 2248, 2022 | 16 | 2022 |
| Nuclear localization of p65 reverses therapy-induced senescence S Salunkhe, SV Mishra, J Nair, S Shah, N Gardi, R Thorat, D Sarkar, ... Journal of cell science 134 (6), jcs253203, 2021 | 16 | 2021 |
| Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells J Rajendra, KK Datta, SBUD Farooqee, R Thorat, K Kumar, N Gardi, ... Oncotarget 9 (45), 27667, 2018 | 13 | 2018 |
| CytoPred: 7-gene pair metric for AML cytogenetic risk prediction S Salunkhe, N Chandran, P Chandrani, A Dutt, S Dutt Briefings in Bioinformatics 21 (1), 348-354, 2020 | 5 | 2020 |
| BEND4, a Novel Prognostic Marker for Adverse AML A Banerjee, SV Mishra, S Salunkhe, P Chandrani, S Dutt Indian Journal of Medical and Paediatric Oncology 43 (S 01), A019, 2022 | | 2022 |
Shilpee DuttPrincipal Investigator at Tata Memorial Centre, ACTREC在 actrec.gov.in 的电子邮件经过验证
